These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 19875277

  • 1. Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD.
    Ichinose M, Seyama K, Nishimura M, Fukuchi Y, Nagai A, Mishima M, Kubo K, Beta-2 Agonist Research and Evaluation Committee in COPD (BAREC) Study Group.
    Respir Med; 2010 Feb; 104(2):267-74. PubMed ID: 19875277
    [Abstract] [Full Text] [Related]

  • 2. Effects of inhaled tiotropium plus transdermal tulobuterol versus tiotropium alone on impulse oscillation system (IOS)-assessed measures of peripheral airway resistance and reactance, lung function and quality of life in patients with COPD: a randomized crossover study.
    Abe T, Setoguchi Y, Kono Y, Togashi Y, Sugiyama S, Tanakadate M, Soeda S, Nakai M, Sugiyama N, Fujiwara A, Yamaguchi K, Yamaguchi A, Kurita N.
    Pulm Pharmacol Ther; 2011 Oct; 24(5):617-24. PubMed ID: 21689775
    [Abstract] [Full Text] [Related]

  • 3. Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal beta(2)-agonist.
    Akamatsu K, Yamagata T, Takahashi T, Miura K, Maeda S, Yamagata Y, Ichikawa T, Yanagisawa S, Ueshima K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M.
    Pulm Pharmacol Ther; 2007 Oct; 20(6):701-7. PubMed ID: 17049894
    [Abstract] [Full Text] [Related]

  • 4. Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients.
    Ichinose M, Fujimoto T, Fukuchi Y.
    Respir Med; 2010 Feb; 104(2):228-36. PubMed ID: 19969446
    [Abstract] [Full Text] [Related]

  • 5. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y, Tateishi Y, Umeda N, Yoshikawa T, Kamoi H, Kanazawa H, Kudoh S, Hirata K, Fujimoto S.
    Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
    [Abstract] [Full Text] [Related]

  • 6. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.
    Tashkin DP, Hanania NA, McGinty J, Denis-Mize K, Chaudry I.
    Adv Ther; 2009 Nov; 26(11):1024-34. PubMed ID: 19953349
    [Abstract] [Full Text] [Related]

  • 7. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M, UPLIFT Study Investigators.
    N Engl J Med; 2008 Oct 09; 359(15):1543-54. PubMed ID: 18836213
    [Abstract] [Full Text] [Related]

  • 8. Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
    Adams SG, Anzueto A, Briggs DD, Menjoge SS, Kesten S.
    Respir Med; 2006 Sep 09; 100(9):1495-503. PubMed ID: 16698259
    [Abstract] [Full Text] [Related]

  • 9. Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study.
    Jung KS, Park HY, Park SY, Kim SK, Kim YK, Shim JJ, Moon HS, Lee KH, Yoo JH, Lee SD, Korean Academy of Tuberculosis and Respiratory Diseases study group, Korea Chronic Obstructive Pulmonary Disease study group.
    Respir Med; 2012 Mar 09; 106(3):382-9. PubMed ID: 21975275
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.
    Donohue JF, Fogarty C, Lötvall J, Mahler DA, Worth H, Yorgancioglu A, Iqbal A, Swales J, Owen R, Higgins M, Kramer B, INHANCE Study Investigators.
    Am J Respir Crit Care Med; 2010 Jul 15; 182(2):155-62. PubMed ID: 20463178
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD.
    Tashkin DP, Donohue JF, Mahler DA, Huang H, Goodwin E, Schaefer K, Hanrahan JP, Andrews WT.
    Respir Med; 2009 Apr 15; 103(4):516-24. PubMed ID: 19208459
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preoperative use of inhaled tiotropium in lung cancer patients with untreated COPD.
    Kobayashi S, Suzuki S, Niikawa H, Sugawara T, Yanai M.
    Respirology; 2009 Jul 15; 14(5):675-9. PubMed ID: 19476597
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.
    van Noord JA, Cornelissen PJ, Aumann JL, Platz J, Mueller A, Fogarty C.
    Respir Med; 2009 Jan 15; 103(1):22-9. PubMed ID: 19022642
    [Abstract] [Full Text] [Related]

  • 20. A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison.
    Rennard S, Bantje T, Centanni S, Chanez P, Chuchalin A, D'Urzo A, Kornmann O, Perry S, Jack D, Owen R, Higgins M.
    Respir Med; 2008 Jul 15; 102(7):1033-44. PubMed ID: 18479895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.